14.12.2009 • News

Dishman Names CRAMS President

Dishman Group of Ahmedabad, India, announced the appointment of Nick Green to the newly created position of president, Dishman Contract Research and Manufacturing Services (CRAMS). Green will assume responsibility for management and operations of all contract research, contract development and contract manufacturing activities within the Dishman Group, which encompasses both the CRAMS services offered under the Dishman name and under the Carbogen Amcis name (the wholly owned Switzerland-based subsidiary of Dishman). Green previously served as president of Codexis Pharmaceuticals. Prior to Codexis, he served as CEO and managing director of Shasun Pharma Solutions, and prior to that, as president and CEO of Rhodia Pharma Solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.